Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra M Levine

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
Complementary Therapies in Medicine|May 15, 2012
An investigation of the possible interaction between the use of Vitamin C and highly active antiretroviral therapy (HAART) adherence and effectiveness in treated HIV+ womenDaniel Merenstein, Cuiwei Wang, Monica Gandhi, et al.
Journal of Virology|December 28, 2005
Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6Keigo Machida, Kevin T H Cheng, Vicky M-H Sung, et al.
AIDS (London, England)|September 27, 2005
Neuropsychological functioning in a cohort of HIV- and hepatitis C virus-infected womenJean L Richardson, Marek Nowicki, Kathleen Danley, et al.
Investigational New Drugs|January 7, 2004
Treatment of AIDS related non-Hodgkin's lymphoma with combination mitoguazone dihydrochloride and low dose CHOP chemotherapy: results of a phase II studyAnil Tulpule, Byron M Espina, A B Pedro Santabarbara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of responseAlexandra M Levine, Anil Tulpule, Byron Espina, et al.
Journal of Virology|July 29, 2004
Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genesKeigo Machida, Kevin T-H Cheng, Vicky M-H Sung, et al.
Leukemia & Lymphoma|February 28, 2007
A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphomaSoon-Thye Lim, L Fayad, A Tulpule, et al.
American Journal of Public Health|July 1, 2004
Medically eligible women who do not use HAART: the importance of abuse, drug use, and raceMardge H Cohen, Judith A Cook, Dennis Grey, et al.
Leukemia Research|January 5, 2002
Multidrug resistance (MDR-1) expression in AIDS-related lymphomasAnil Tulpule, Andy Sherrod, Dharshika Dharmapala, et al.
AIDS (London, England)|August 11, 2007
Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV StudyPhyllis C Tien, Michael F Schneider, Stephen R Cole, et al.
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Complementary Therapies in Medicine|May 15, 2012
An investigation of the possible interaction between the use of Vitamin C and highly active antiretroviral therapy (HAART) adherence and effectiveness in treated HIV+ womenDaniel Merenstein, Cuiwei Wang, Monica Gandhi, et al.
Journal of Virology|December 28, 2005
Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6Keigo Machida, Kevin T H Cheng, Vicky M-H Sung, et al.
AIDS (London, England)|September 27, 2005
Neuropsychological functioning in a cohort of HIV- and hepatitis C virus-infected womenJean L Richardson, Marek Nowicki, Kathleen Danley, et al.
Investigational New Drugs|January 7, 2004
Treatment of AIDS related non-Hodgkin's lymphoma with combination mitoguazone dihydrochloride and low dose CHOP chemotherapy: results of a phase II studyAnil Tulpule, Byron M Espina, A B Pedro Santabarbara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of responseAlexandra M Levine, Anil Tulpule, Byron Espina, et al.
Journal of Virology|July 29, 2004
Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genesKeigo Machida, Kevin T-H Cheng, Vicky M-H Sung, et al.
Leukemia & Lymphoma|February 28, 2007
A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphomaSoon-Thye Lim, L Fayad, A Tulpule, et al.
American Journal of Public Health|July 1, 2004
Medically eligible women who do not use HAART: the importance of abuse, drug use, and raceMardge H Cohen, Judith A Cook, Dennis Grey, et al.
Leukemia Research|January 5, 2002
Multidrug resistance (MDR-1) expression in AIDS-related lymphomasAnil Tulpule, Andy Sherrod, Dharshika Dharmapala, et al.
AIDS (London, England)|August 11, 2007
Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV StudyPhyllis C Tien, Michael F Schneider, Stephen R Cole, et al.
Pageof 12